Aeternum Health (AETN) Cash from Financing Activities (2010 - 2026)

Aeternum Health has disclosed Cash from Financing Activities across 16 years of filings, most recently posting $60000.0 for Q1 2026.

• In Q1 2026, Cash from Financing Activities changed N/A year-over-year to $60000.0; the TTM figure through Mar 2026 stood at -$15445.0 (changed N/A YoY), while the FY2024 annual figure was -$113245.0, down 120.7% from the prior year.
• Cash from Financing Activities grew to $60000.0 in Q1 2026, from -$1.0 in the prior quarter.
• Over the last five years, Cash from Financing Activities for AETN reached as high as $352683.0 in Q1 2023 and fell as low as -$51600.0 in Q2 2024.
• The 4-year median for Cash from Financing Activities is -$3750.0 (2022), against an average of $37717.2.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities sank 101.05% — and 2023, when it slumped 833.33%.
• A 4-year view of Cash from Financing Activities shows it stood at -$4500.0 in 2022, then slumped by 522.22% to -$28000.0 in 2023, then jumped by 100.0% to -$1.0 in 2024, then soared by 6000100.0% to $60000.0 in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered $60000.0, -$1.0, and -$23844.0 for Q1 2026, Q4 2024, and Q3 2024 respectively.